Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Merck & Co Inc (NYSE:MRK)

63.18
Delayed Data
As of Mar 24
 -0.10 / -0.16%
Today’s Change
52.44
Today|||52-Week Range
66.80
+7.32%
Year-to-Date

Today’s Trading

Previous close63.28
Today’s open63.16
Day’s range62.86 - 63.53
Volume9,136,531
Average volume (3 months)10,420,135
Market cap$173.5B
Dividend yield2.98%
Data as of 4:01pm ET, 03/24/2017

Growth & Valuation

Earnings growth (last year)-9.62%
Earnings growth (this year)+0.80%
Earnings growth (next 5 years)+6.50%
Revenue growth (last year)+1.86%
P/E ratio44.8
Price/Sales4.15
Price/Book4.33

Competitors

 Today’s
change
Today’s
% change
NVSNovartis-0.06-0.08%
PFEPfizer-0.29-0.85%
SNYSanofi+0.12+0.27%
ABBVAbbVie-0.03-0.05%
Data as of 4:02pm ET, 03/24/2017

Financials

Next reporting dateMay 2, 2017
EPS forecast (this quarter)$0.84
Annual revenue (last year)$39.5B
Annual profit (last year)$3.9B
Net profit margin9.93%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chairman, President &
Chief Executive Officer
Kenneth C. Frazier
Chief Financial Officer &
Executive Vice President
Robert M. Davis
Corporate headquarters
Kenilworth, New Jersey

Forecasts


Search for Jobs